Gagro Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.52 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -27.50%
- Profit Growth 82.66%
- Ebitda 91.08%
- Net Worth -11.66%
- Total Assets -22.66%
About Gagro Biotech
Gagro Biotech Limited (GBL) is a Public Limited Indian Non-Government Company incorporated in India on 19 August 2019 (Five years and five months 13 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.52 M, as per Ministry of Corporate Affairs (MCA) records.
Biplob Mohonta, Sashangka Das, and Dipamani Deka serve as directors at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U01409AS2019PLC019443
- Company No.
019443
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2019
- Date of AGM
31 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
What products or services does Gagro Biotech Limited offer?
Gagro Biotech Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Kitchen Cleaners.
Who are the key members and board of directors at Gagro Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Biplob Mohonta  | Director | 19-Aug-2019 | Current |
| Sashangka Das | Director | 19-Aug-2019 | Current |
| Dipamani Deka | Director | 19-Aug-2019 | Current |
Financial Performance of Gagro Biotech.
Gagro Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 27.5% decrease. The company also saw a substantial improvement in profitability, with a 82.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gagro Biotech?
Unlock access to Gagro Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gagro Biotech?
Unlock and access historical data on people associated with Gagro Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gagro Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gagro Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.